Sangamo Therapeutics Announces Fourth Quarter and Full Year 2020 Conference Call and Webcast
February 17 2021 - 4:15PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that the Company has scheduled the release
of its fourth quarter and full year 2020 financial results after
the market closes on Wednesday, February 24, 2021. The press
release will be followed by a conference call at 5:00 p.m. ET,
which will be open to the public via telephone and webcast. During
the conference call, the Company will review its financial results
and provide business updates.
The conference call dial-in numbers are (877) 377-7553 for
domestic callers and (678) 894-3968 for international callers. The
conference ID number for the call is 1795427. Participants may
access the live webcast via a link on the Sangamo Therapeutics
website in the Investors and Media section under Events and
Presentations. A conference call replay will be available for one
week following the conference call. The conference call replay
numbers for domestic and international callers are (855) 859-2056
and (404) 537-3406, respectively. The conference ID number for the
replay is 1795427.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, cell therapy, and genome
engineering. For more information about Sangamo, visit
www.sangamo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210217005763/en/
Investor & Media Inquiries Aron
Feingold 628-252-7494 afeingold@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2023 to Sep 2024